Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Spriggs

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 29, 2006
Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancerF C Maluf, A L Leiser, C Aghajanian, et al.
The Journal of Experimental Medicine|January 1, 1982
Identification of a hemagglutinin-specific idiotype associated with reovirus recognition shared by lymphoid and neural cellsJ T Nepom, H L Weiner, M A Dichter, et al.
Cancer|January 15, 1992
Clinical and biologic effects of combination therapy with gamma-interferon and tumor necrosis factorJ H Schiller, P L Witt, B Storer, et al.
Surgery|August 1, 1988
Tumor necrosis factor and endotoxin induce similar metabolic responses in human beingsH R Michie, D R Spriggs, K R Manogue, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2010
Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivityD J Gallagher, J A Konner, K M Bell-McGuinn, et al.
The Journal of Infectious Diseases|October 1, 1995
Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1J R Kenner, T S Coster, D N Taylor, et al.
Lancet (London, England)|April 15, 1995
Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototypeT S Coster, K P Killeen, M K Waldor, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 13, 2007
Paclitaxel and carboplatin in the treatment of advanced or recurrent endometrial cancer: a large retrospective studyM A Sovak, J Dupont, M L Hensley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancerC Aghajanian, D Fennelly, F Shapiro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2014
The performance of BRCA1 immunohistochemistry for detecting germline, somatic, and epigenetic BRCA1 loss in high-grade serous ovarian cancerJ L Meisel, D M Hyman, K Garg, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 29, 2006
Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancerF C Maluf, A L Leiser, C Aghajanian, et al.
The Journal of Experimental Medicine|January 1, 1982
Identification of a hemagglutinin-specific idiotype associated with reovirus recognition shared by lymphoid and neural cellsJ T Nepom, H L Weiner, M A Dichter, et al.
Cancer|January 15, 1992
Clinical and biologic effects of combination therapy with gamma-interferon and tumor necrosis factorJ H Schiller, P L Witt, B Storer, et al.
Surgery|August 1, 1988
Tumor necrosis factor and endotoxin induce similar metabolic responses in human beingsH R Michie, D R Spriggs, K R Manogue, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2010
Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivityD J Gallagher, J A Konner, K M Bell-McGuinn, et al.
The Journal of Infectious Diseases|October 1, 1995
Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1J R Kenner, T S Coster, D N Taylor, et al.
Lancet (London, England)|April 15, 1995
Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototypeT S Coster, K P Killeen, M K Waldor, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 13, 2007
Paclitaxel and carboplatin in the treatment of advanced or recurrent endometrial cancer: a large retrospective studyM A Sovak, J Dupont, M L Hensley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancerC Aghajanian, D Fennelly, F Shapiro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2014
The performance of BRCA1 immunohistochemistry for detecting germline, somatic, and epigenetic BRCA1 loss in high-grade serous ovarian cancerJ L Meisel, D M Hyman, K Garg, et al.
Pageof 10